CIK 0001603454 · Non-accelerated filer<br>Smaller reporting company
Celcuity Inc.
Sign in to watch- Ticker
- CELC
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 763-392-0767
- Business address
- 16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
- Former names
- Celcuity LLC
- 8-K Event Material agreement · Shareholder rights changed · Executive or director change
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,000 shares at $8.99 ($44,939)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 100 shares at $10.02 ($1,002)
- 8-K Event Shareholder vote results
- 4 Open-market sale Director sold 350 shares at an average $10.01 ($3,503)
- 4 Open-market sale Director sold 300 shares at $8.95 ($2,685)
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Results of operations · New debt or obligation
- 8-K Event Material agreement
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market sale Director sold 300 shares at $9.47 ($2,841)
- S-8 Other Securities Offered to Employees in Benefit Plans
- D Other Notice of Sales of Unregistered Securities
- 4 Open-market buy Director bought 754 shares at $5.94 ($4,482)
- SC 13G Stake Amended Statement of Ownership
Page 16 of 28 · 542 filings